Yuka Kato

1.6k total citations
74 papers, 1.1k citations indexed

About

Yuka Kato is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuka Kato has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Yuka Kato's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (12 papers) and Colorectal Cancer Treatments and Studies (9 papers). Yuka Kato is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (12 papers) and Colorectal Cancer Treatments and Studies (9 papers). Yuka Kato collaborates with scholars based in Japan, United States and Sweden. Yuka Kato's co-authors include Michiya Fujiki, Yoshihisa Inoue, Hiroki Tanaka, Tadashi Mori, Noriaki Minakawa, Akira Matsuda, Katsuyuki Kiura, Kazushi Asano, Katsuyuki Hotta and Shigeo Tanaka and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yuka Kato

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuka Kato Japan	19	321	308	307	249	174	74	1.1k
Julio A. Díaz-Pérez United States	20	344 1.1×	390 1.3×	176 0.6×	629 2.5×	143 0.8×	106	1.8k
Xiao Li China	22	507 1.6×	171 0.6×	232 0.8×	374 1.5×	53 0.3×	142	1.6k
Yoshihiro Honda Japan	17	238 0.7×	435 1.4×	160 0.5×	690 2.8×	84 0.5×	95	1.5k
Derek D. Doorneweerd United States	10	658 2.0×	97 0.3×	155 0.5×	135 0.5×	248 1.4×	12	1.5k
Kuniaki Itoh Japan	23	354 1.1×	193 0.6×	237 0.8×	866 3.5×	104 0.6×	125	1.9k
Balaji Venugopal United Kingdom	14	446 1.4×	367 1.2×	138 0.4×	268 1.1×	301 1.7×	56	1.4k
Tetsuya Inoue Japan	23	211 0.7×	487 1.6×	390 1.3×	228 0.9×	90 0.5×	131	1.8k
Athanasios Galanis Greece	15	458 1.4×	66 0.2×	174 0.6×	199 0.8×	187 1.1×	38	980
Edmund J. Keliher United States	27	870 2.7×	216 0.7×	460 1.5×	525 2.1×	252 1.4×	45	2.4k
Inna Solomonov Israel	22	644 2.0×	84 0.3×	86 0.3×	353 1.4×	109 0.6×	38	1.6k

Countries citing papers authored by Yuka Kato

Since Specialization

Citations

This map shows the geographic impact of Yuka Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Kato more than expected).

Fields of papers citing papers by Yuka Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Kato. The network helps show where Yuka Kato may publish in the future.

Co-authorship network of co-authors of Yuka Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Kato. A scholar is included among the top collaborators of Yuka Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Kato. Yuka Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makimoto, Go, Takaaki Tanaka, Yuka Kato, et al.. (2024). A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol. Respiratory Investigation. 62(5). 897–900. 1 indexed citations

Sakaguchi, Kimiyoshi, et al.. (2023). The process of becoming independent while balancing health management and social life in adolescent and young adult childhood cancer survivors. Japan Journal of Nursing Science. 20(3). e12527–e12527. 2 indexed citations

Sakaguchi, Kimiyoshi, et al.. (2023). The parental involvement process regarding childhood cancer survivors becoming independent: Focus on balancing health management and social lives from adolescence to adulthood. Japan Journal of Nursing Science. 21(2). e12572–e12572.

Hosokawa, Shinobu, Eiki Ichihara, Daijiro Harada, et al.. (2022). Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801. International Journal of Clinical Oncology. 27(7). 1139–1144. 4 indexed citations

Makimoto, Go, Kiichiro Ninomiya, Hisao Higo, et al.. (2022). Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization. Respiratory Medicine Case Reports. 38. 101669–101669. 1 indexed citations

Kano, Hirohisa, Eiki Ichihara, Hiromi Watanabe, et al.. (2021). SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non–small Cell Lung Cancer. Molecular Cancer Therapeutics. 20(9). 1653–1662. 13 indexed citations

Kayatani, Hiroe, Kadoaki Ohashi, Kiichiro Ninomiya, et al.. (2020). Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations. Biochemical and Biophysical Research Communications. 532(3). 341–346. 7 indexed citations

Nishii, Kazuya, Katsuyuki Hotta, Kiichiro Ninomiya, et al.. (2019). Programmed cell death-ligand 1 expression and efficacy of cisplatin-based chemotherapy in lung cancer: A sub-analysis of data from the two Okayama Lung Cancer Study Group prospective feasibility studies. Respiratory Investigation. 57(5). 460–465. 2 indexed citations

Tamura, Tomoki, Yuka Kato, Kadoaki Ohashi, et al.. (2017). Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations. Biochemical and Biophysical Research Communications. 495(1). 360–367. 15 indexed citations

10.

Kato, Yuka, et al.. (2016). Characterization of MazF-Mediated Sequence-Specific RNA Cleavage in Pseudomonas putida Using Massive Parallel Sequencing. PLoS ONE. 11(2). e0149494–e0149494. 12 indexed citations

11.

Hotta, Katsuyuki, Yuka Kato, Natasha B. Leighl, et al.. (2015). Magnitude of the Benefit of Progression-Free Survival as a Potential Surrogate Marker in Phase 3 Trials Assessing Targeted Agents in Molecularly Selected Patients with Advanced Non-Small Cell Lung Cancer: Systematic Review. PLoS ONE. 10(3). e0121211–e0121211. 14 indexed citations

12.

Kato, Yuka, et al.. (2013). Therapy of tinnitus using a hearing aid with a music and sound generator function. AUDIOLOGY JAPAN. 56(1). 59–64.

13.

Muraoka, Yuji, Kenta Iwai, Takanori Wakita, et al.. (2011). Preparation of the CrO₂ thin films using a Cr₈O₂₁ precursor. MRS Proceedings. 1292. 1 indexed citations

14.

Hotta, Katsuyuki, Katsuyuki Kiura, Nagio Takigawa, et al.. (2010). Desire for Information and Involvement in Treatment Decisions: Lung Cancer Patients' Preferences and Their Physicians' Perceptions: Results from Okayama Lung Cancer Study Group Trial 0705. Journal of Thoracic Oncology. 5(10). 1668–1672. 18 indexed citations

15.

Segawa, Yoshihiko, Masanori Fujii, Isao Oze, et al.. (2009). Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications. Journal of Cancer Research and Clinical Oncology. 135(8). 1055–1059. 29 indexed citations

16.

TESHIMA, Kenji, Kazushi Asano, Koji Iwanaga, et al.. (2006). Evaluation of Right Ventricular Tei Index (Index of Myocardial Performance) in Healthy Dogs and Dogs with Tricuspid Regurgitation(Internal Medicine). Journal of Veterinary Medical Science. 68(12). 1307–1313. 10 indexed citations

17.

Minakawa, Noriaki, Shuichi Hoshika, Naonori Inoue, Yuka Kato, & Akira Matsuda. (2005). 4'-Thionucleic Acids: Chemistry, Properties, and Applications for Developing Functional Oligonucleotides. 1(1). 79–102. 1 indexed citations

18.

Minakawa, Noriaki, et al.. (2003). Synthesis and Structural Elucidation of 1‐(3‐C‐Ethynyl‐4‐thio‐β‐D‐ribofuranosyl)cytosine (4′‐ThioECyd).. ChemInform. 34(7). 1 indexed citations

19.

Minakawa, Noriaki, et al.. (2002). Synthesis and structural elucidation of 1-(3-C-ethynyl-4-thio-β-D-ribofuranosyl)cytosine (4′-thioECyd). Journal of the Chemical Society Perkin Transactions 1. 2182–2189. 23 indexed citations

20.

MacLean, D. A., et al.. (2000). Glossary of Terms Used in Combinatorial Chemistry (Technical Report). Journal of Combinatorial Chemistry. 2(6). 562–578. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact